Publications by authors named "Richard Boucher"

In asthma, tissue factor (TF) levels are elevated in the lung. In our previous studies using mechanically compressed human bronchial epithelial (HBE) cells, which are a well-defined in vitro model of bronchoconstriction during asthma exacerbations, we detected TF within extracellular vesicles (EVs) released from compressed HBE cells. Here, to better characterize the potential role of this mechanism in asthma, we tested the extent to which the transcriptional regulation of epithelial cell-derived TF varied between donors with and without asthma.

View Article and Find Full Text PDF

Airway multiciliated cells (MCs) maintain respiratory health by clearing mucus and trapped particles through the beating of motile cilia. While it is known that ciliary lengths decrease along the proximal-distal (P-D) axis of the tracheobronchial tree, how this is regulated is unclear. Here, we demonstrate that canonical Notch signaling in MCs plays a critical role in stabilizing ciliary length.

View Article and Find Full Text PDF

Black soldier fly larvae meal (BSFM) from has emerged as a dependable protein source in aquaculture. This study aimed to assess BSFM's digestibility in barramundi juveniles and compare it to soy protein concentrate meal (SPCM). Four diets (control, 30% BSFM; 30% SPCM; and commercial feed control) were tested on 1,800 barramundi juveniles (weight: 71.

View Article and Find Full Text PDF
Article Synopsis
  • Mirvetuximab soravtansine-gynx can cause a lung problem called interstitial lung disease (ILD).
  • This lung issue can show up as a specific pattern called organizing pneumonia in medical images.
  • Doctors often use steroids to help treat this lung problem caused by mirvetuximab, and there are important updates on how to dose the medicine if someone has mild lung symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Hyper IgE syndrome (STAT3-HIES), also known as Job's syndrome, results from mutations in the STAT3 gene, leading to chronic respiratory infections due to compromised pulmonary defense mechanisms.
  • The study aimed to investigate how these STAT3 mutations affect the airway epithelium's ability to defend against infections, analyzing sputum properties and lung tissue from patients.
  • Findings revealed that STAT3 deficiency disrupts critical airway functions, including mucus secretion and ciliary movement, contributing to increased infection risk and inflammation in patients with this syndrome.*
View Article and Find Full Text PDF
Article Synopsis
  • The SPIROMICS Study of Early COPD Progression (SOURCE) aims to investigate the biological reasons behind early-stage COPD in younger individuals who smoke, addressing a gap in current medical knowledge that hinders treatment development.
  • The study plans to enroll 649 participants aged 30-55 with a history of smoking, alongside 40 never-smoker controls, to collect comprehensive health data and analyze potential mechanisms of disease progression.
  • SOURCE seeks to use advanced imaging and biospecimen collection methods over three years to enhance understanding of COPD and contribute to better prevention and treatment strategies.
View Article and Find Full Text PDF

The severe acute respiratory syndrome coronavirus 2 pandemic is characterized by the emergence of novel variants of concern (VOCs) that replace ancestral strains. Here, we dissect the complex selective pressures by evaluating variant fitness and adaptation in human respiratory tissues. We evaluate viral properties and host responses to reconstruct forces behind D614G through Omicron (BA.

View Article and Find Full Text PDF

In vitro models play a major role in studying airway physiology and disease. However, the native lung's complex tissue architecture and non-epithelial cell lineages are not preserved in these models. Ex vivo tissue models could overcome in vitro limitations, but methods for long-term maintenance of ex vivo tissue has not been established.

View Article and Find Full Text PDF
Article Synopsis
  • The airway microbiome may influence the development and progression of chronic obstructive pulmonary disease (COPD), but its impact on milder cases remains unclear.
  • The study analyzed sputum DNA from 877 participants, mostly with milder COPD (stages 0-2), to examine the relationship between microbiome characteristics and various health markers.
  • It found that greater diversity in the airway microbiome correlated with better lung function and fewer symptoms, while lower diversity was linked to worse outcomes, suggesting that microbiome features could help predict lung health over time.
View Article and Find Full Text PDF

Background: Whether there is any benefit in integrating culture-independent molecular analysis of the lower airway microbiota of people with cystic fibrosis into clinical care is unclear. This study determined the longitudinal trajectory of the microbiota and if there were microbiota characteristics that corresponded with response to treatment or predicted a future pulmonary exacerbation.

Methods: At least one sputum sample was collected from 149 participants enrolled in this prospective longitudinal multi-centre study and total bacterial density and microbiota community measurements were determined and compared with clinical parameters.

View Article and Find Full Text PDF

Non-cystic fibrosis bronchiectasis (NCFB) may originate in bronchiolar regions of the lung. Accordingly, there is a need to characterize the morphology and molecular characteristics of NCFB bronchioles. Test the hypothesis that NCFB exhibits a major component of bronchiolar disease manifest by mucus plugging and ectasia.

View Article and Find Full Text PDF
Article Synopsis
  • CFTR modulator drugs improve lung function and body mass index in cystic fibrosis patients, but inflammation remains a challenge, indicating a need to target the underlying causes in the lungs of patients with established disease.* -
  • The study explores the presence of unique, potentially pathogenic stem cell variants in cystic fibrosis lungs, similar to those found in COPD, and aims to identify which of these variants contribute to ongoing inflammation.* -
  • Research utilized advanced stem cell cloning technology on end-stage CF lungs to identify five predominant stem cell variants, three of which are pro-inflammatory, highlighting the complexity of stem cell involvement in cystic fibrosis lung inflammation.*
View Article and Find Full Text PDF

Background: Previous SARS-CoV-2 infection and vaccination, coupled with the rapid evolution of SARS-CoV-2 variants, have modified COVID-19 clinical manifestations. We aimed to characterise the clinical symptoms of COVID-19 individuals in omicron BA.2 and BA.

View Article and Find Full Text PDF

The human airways are complex structures with important interactions between cells, extracellular matrix (ECM) proteins and the biomechanical microenvironment. A robust, well-differentiated in vitro culture system that accurately models these interactions would provide a useful tool for studying normal and pathological airway biology. Here, we report the development and characterization of a physiologically relevant air-liquid interface (ALI) 3D airway 'organ tissue equivalent' (OTE) model with three novel features: native pulmonary fibroblasts, solubilized lung ECM, and hydrogel substrate with tunable stiffness and porosity.

View Article and Find Full Text PDF
Article Synopsis
  • Human airway epithelia obtain oxygen from air rather than blood, which makes them susceptible to issues like mucus plugs due to various pulmonary diseases.
  • Chronic hypoxia (CH) in airway epithelia has been linked to increased MUC5B mucin production and altered ion absorption, contributing to mucus accumulation and airway obstruction.
  • This study reveals that chronic hypoxia may play a significant role in the progression of muco-obstructive lung diseases (MOLDs) by affecting airway remodeling and resulting in further airway damage.
View Article and Find Full Text PDF

Accelerated progression of chronic obstructive pulmonary disease (COPD) is associated with increased risks of hospitalization and death. Prognostic insights into mechanisms and markers of progression could facilitate development of disease-modifying therapies. Although individual biomarkers exhibit some predictive value, performance is modest and their univariate nature limits network-level insights.

View Article and Find Full Text PDF

The SARS-CoV-2 coronavirus continues to evolve with scores of mutations of the spike, membrane, envelope, and nucleocapsid structural proteins that impact pathogenesis. Infection data from nasal swabs, nasal PCR assays, upper respiratory samples, ex vivo cell cultures and nasal epithelial organoids reveal extreme variabilities in SARS-CoV-2 RNA titers within and between the variants. Some variabilities are naturally prone to clinical testing protocols and experimental controls.

View Article and Find Full Text PDF

Background: Previous SARS-CoV-2 infection and vaccination, coupled to rapid evolution of SARS-CoV-2 variants, have modified COVID-19 clinical manifestations. We characterized clinical symptoms of COVID-19 individuals in omicron BA.2 and BA.

View Article and Find Full Text PDF

Elevated levels of cytokines IL-1β and IL-6 are associated with severe COVID-19. Investigating the underlying mechanisms, we find that while primary human airway epithelia (HAE) have functional inflammasomes and support SARS-CoV-2 replication, they are not the source of IL-1β released upon infection. In leukocytes, the SARS-CoV-2 E protein upregulates inflammasome gene transcription via TLR2 to prime, but not activate, inflammasomes.

View Article and Find Full Text PDF

Nicotine from cigarette smoke is a biologically active molecule that has pleiotropic effects in the airway, which could play a role in smoking-induced lung disease. However, whether nicotine and its metabolites reach sustained, physiologically relevant concentrations on airway surfaces of smokers is not well defined. To address these issues, concentrations of nicotine, cotinine, and hydroxycotinine were measured by mass spectrometry (MS) in supernatants of induced sputum obtained from participants in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS), an ongoing observational study that included never smokers, former smokers, and current smokers with and without chronic obstructive pulmonary disease (COPD).

View Article and Find Full Text PDF
Article Synopsis
  • Disseminated coccidioidomycosis (DCM) is a serious illness caused by Coccidioides fungi, primarily affecting individuals in the southwestern U.S. and Mexico, with only 30% of infected individuals showing symptoms and less than 1% developing DCM.
  • Through whole-exome sequencing of 67 DCM patients, researchers identified genetic mutations, including haploinsufficient STAT3 and defects in β-glucan sensing and response, in a significant number of cases, influencing disease dissemination.
  • A validation study with an additional 111 patients confirmed specific variants in genes like CLEC7A and PLCG2 that linked to weakened immune responses, indicating that impaired recognition of the fungi and lowered cytok
View Article and Find Full Text PDF
Article Synopsis
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a spectrum of symptoms ranging from mild illness to severe respiratory distress, highlighting the need to understand how host factors affect infection.
  • The study utilized genome-wide CRISPR screens in human lung cells to identify various host factors involved in SARS-CoV-2 interactions, including those related to transport, inflammation, and cell regulation.
  • Notably, the researchers found that mucins, which are high molecular weight proteins, play a key role in restricting SARS-CoV-2 infection and could serve as potential targets for new therapies.
View Article and Find Full Text PDF

Infectious diseases have shaped the human population genetic structure, and genetic variation influences the susceptibility to many viral diseases. However, a variety of challenges have made the implementation of traditional human Genome-wide Association Studies (GWAS) approaches to study these infectious outcomes challenging. In contrast, mouse models of infectious diseases provide an experimental control and precision, which facilitates analyses and mechanistic studies of the role of genetic variation on infection.

View Article and Find Full Text PDF

A subset of individuals who recover from coronavirus disease 2019 (COVID-19) develop post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC), but the mechanistic basis of PASC-associated lung abnormalities suffers from a lack of longitudinal tissue samples. The mouse-adapted SARS-CoV-2 strain MA10 produces an acute respiratory distress syndrome in mice similar to humans. To investigate PASC pathogenesis, studies of MA10-infected mice were extended from acute to clinical recovery phases.

View Article and Find Full Text PDF

The incidence and sites of mucus accumulation and molecular regulation of mucin gene expression in coronavirus (COVID-19) lung disease have not been reported. To characterize the incidence of mucus accumulation and the mechanisms mediating mucin hypersecretion in COVID-19 lung disease. Airway mucus and mucins were evaluated in COVID-19 autopsy lungs by Alcian blue and periodic acid-Schiff staining, immunohistochemical staining, RNA hybridization, and spatial transcriptional profiling.

View Article and Find Full Text PDF